^
Association details:
Biomarker:No biomarker
Cancer:Glioblastoma
Drug:Vegzelma (bevacizumab-adcd) (VEGF-A inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A1 - Approval
New
Source:
Excerpt:
VEGZELMA is a vascular endothelial growth factor inhibitor indicated for the treatment of...Recurrent glioblastoma in adults.